Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4

Oncotarget

Volumn 8, Issue 14, 2017, Pages 23750-23759

  Royet, Amélie ^a,b   Broutier, Laura ^a   Coissieux, Marie May ^a   Malleval, Céline ^a   Gadot, Nicolas ^c   Maillet, Denis ^a   Gratadou Hupon, Lise ^a,b   Bernet, Agnès ^a,b   Nony, Pascale ^b   Treilleux, Isabelle ^c   Honnorat, Jérôme ^a   Liebl, Daniel ^d   Pelletier, Laurent ^e   Berger, François ^e   Meyronet, David ^f   Castets, Marie ^a   Mehlen, Patrick ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b Netris Pharma   (France)

^c CENTRE LÉON BÉRARD   (France)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^f HOSPICES CIVILS DE LYON   (France)

Author keywords

Angiogenesis; Apoptosis; Dependence receptors; Ephrin B3 EphA4; Glioblastoma

Indexed keywords

EPHRIN B3; EPHRIN RECEPTOR A4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLIOBLASTOMA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VASCULARIZATION; ZEBRA FISH; ANIMAL; BRAIN TUMOR; CHICK EMBRYO; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHICK EMBRYO; EPHRIN-B3; FEMALE; GLIOBLASTOMA; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, NUDE; RECEPTOR, EPHA4; ZEBRAFISH;

EID: 85016934708     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.16077     Document Type: Article

References (40)

1. Polivka J, Jr., Polivka J, Rohan V, Topolcan O, Ferda J. New molecularly targeted therapies for glioblastoma multiforme. Anticancer Res. 2012; 32:2935-46.
2. Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, Burns DK, Alvarez-Buylla A, Parada LF. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell. 2009; 15:45-56. doi: 10.1016/j.ccr.2008.12.006.
3. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004; 64:7011-21. doi: 10.1158/0008-5472.CAN-04-1364.
4. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet. 2000; 25:55-7. doi: 10.1038/75596.
5. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia. 2002; 39:193-206. doi: 10.1002/glia.10094.
6. Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S. Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro Oncol. 2013; 15:91-6. doi:10.1093/neuonc/nos268.
7. Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol. 2007; 9:424-9. doi: 10.1215/15228517-2007-023.
8. Wang Y, Yang J, Zheng H, Tomasek GJ, Zhang P, McKeever PE, Lee EY, Zhu Y. Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell. 2009; 15:514-26. doi: 10.1016/j.ccr.2009.04.001.
9. Merkle FT, Alvarez-Buylla A. Neural stem cells in mammalian development. Curr Opin Cell Biol. 2006; 18:704-9. doi: 10.1016/j.ceb.2006.09.008.
10. Flanagan JG, Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci. 1998; 21:309-45. doi: 10.1146/annurev.neuro.21.1.309.
11. Helbling PM, Saulnier DM, Brandli AW. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. Development. 2000; 127:269-78.
12. Wilkinson DG. Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci. 2001; 2:155-64. doi: 10.1038/35058515.
13. Noberini R, Koolpe M, Peddibhotla S, Dahl R, Su Y, Cosford ND, Roth GP, Pasquale EB. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors. J Biol Chem. 2008; 283:29461-72. doi: 10.1074/ jbc.M804103200.
14. Kullander K, Butt SJ, Lebret JM, Lundfald L, Restrepo CE, Rydstrom A, Klein R, Kiehn O. Role of EphA4 and EphrinB3 in local neuronal circuits that control walking. Science. 2003; 299:1889-92. doi: 10.1126/science.1079641.
15. Paixao S, Balijepalli A, Serradj N, Niu J, Luo W, Martin JH, Klein R. EphrinB3/EphA4-mediated guidance of ascending and descending spinal tracts. Neuron. 2013; 80:1407-20. doi: 10.1016/j.neuron.2013.10.006.
16. Furne C, Ricard J, Cabrera JR, Pays L, Bethea JR, Mehlen P, Liebl DJ. EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis. Biochim Biophys Acta. 2009; 1793:231-8. doi: 10.1016/j.bbamcr.2008.09.009.
17. Nelersa CM, Barreras H, Runko E, Ricard J, Shi Y, Glass SJ, Bixby JL, Lemmon VP, Liebl DJ. High-content analysis of proapoptotic EphA4 dependence receptor functions using small-molecule libraries. J Biomol Screen. 2012; 17:785-95. doi: 10.1177/1087057112440880.
18. Llambi F, Causeret F, Bloch-Gallego E, Mehlen P. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J. 2001; 20:2715-22. doi: 10.1093/ emboj/20.11.2715.
19. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature. 1998; 395:801-4. doi: 10.1038/27441.
20. Nikoletopoulou V, Lickert H, Frade JM, Rencurel C, Giallonardo P, Zhang L, Bibel M, Barde YA. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature. 2010; 467:59-63. doi: 10.1038/ nature09336.
21. Castets M, Broutier L, Molin Y, Brevet M, Chazot G, Gadot N, Paquet A, Mazelin L, Jarrosson-Wuilleme L, Scoazec JY, Bernet A, Mehlen P. DCC constrains tumour progression via its dependence receptor activity. Nature. 2012; 482:534-7. doi: 10.1038/nature10708.
22. Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, Gespach C, Bredesen DE, Scoazec JY, Mehlen P. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature. 2004; 431:80-4. doi: 10.1038/nature02788.
23. Mehlen P, Delloye-Bourgeois C, Chedotal A. Novel roles for Slits and netrins: axon guidance cues as anticancer targets? Nat Rev Cancer. 2011; 11:188-97. doi: 10.1038/ nrc3005.
24. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, Berens ME. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia. 2005; 7:7-16. doi: 10.1593/neo.04535.
25. Nakada M, Drake KL, Nakada S, Niska JA, Berens ME. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. Cancer Res. 2006; 66:8492-500. doi: 10.1158/0008-5472.CAN-05-4211.
26. Reardon DA, Perry JR, Brandes AA, Jalali R, Wick W. Advances in malignant glioma drug discovery. Expert Opin Drug Discov. 2011; 6:739-53. doi: 10.1517/17460441.2011.584530.
27. Chi A, Norden AD, Wen PY. Inhibition of angiogenesis and invasion in malignant gliomas. Expert Rev Anticancer Ther. 2007; 7:1537-60. doi: 10.1586/14737140.7.11.1537.
28. Yao VJ, Ozawa MG, Trepel M, Arap W, McDonald DM, Pasqualini R. Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection. Am J Pathol. 2005; 166:625-36. doi: 10.1016/S0002-9440(10)62283-3.
29. Ribatti D. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Int Rev Cell Mol Biol. 2008; 270:181-224. doi: 10.1016/S1937-6448(08)01405-6.
30. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002; 248:307-18.
31. Zhong H, Wu X, Huang H, Fan Q, Zhu Z, Lin S. Vertebrate MAX-1 is required for vascular patterning in zebrafish. Proc Natl Acad Sci USA. 2006; 103:16800-5. doi: 10.1073/ pnas.0603959103.
32. Noberini R, Lamberto I, Pasquale EB. Targeting Eph receptors with peptides and small molecules: progress and challenges. Semin Cell Dev Biol. 2012; 23:51-7. doi: 10.1016/j.semcdb.2011.10.023.
33. Mosch B, Reissenweber B, Neuber C, Pietzsch J. Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis. J Oncol. 2010; 2010:135285. doi: 10.1155/2010/135285.
34. Ohka F, Natsume A, Wakabayashi T. Current trends in targeted therapies for glioblastoma multiforme. Neurol Res Int. 2012; 2012:878425. doi: 10.1155/2012/878425.
35. Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer. 2010; 10:165-80. doi: 10.1038/nrc2806.
36. Castets M, Coissieux MM, Delloye-Bourgeois C, Bernard L, Delcros JG, Bernet A, Laudet V, Mehlen P. Inhibition of endothelial cell apoptosis by netrin-1 during angiogenesis. Dev Cell. 2009; 16:614-20. doi: 10.1016/j. devcel.2009.02.006.
37. Delloye-Bourgeois C, Brambilla E, Coissieux MM, Guenebeaud C, Pedeux R, Firlej V, Cabon F, Brambilla C, Mehlen P, Bernet A. Interference with netrin-1 and tumor cell death in non-small cell lung cancer. J Natl Cancer Inst. 2009; 101:237-47. doi: 10.1093/jnci/djn491.
38. Ghoumari AM, Wehrle R, Bernard O, Sotelo C, Dusart I. Implication of Bcl-2 and Caspase-3 in age-related Purkinje cell death in murine organotypic culture: an in vitro model to study apoptosis. Eur J Neurosci. 2000; 12:2935-49.
39. Fombonne J, Bissey PA, Guix C, Sadoul R, Thibert C, Mehlen P. Patched dependence receptor triggers apoptosis through ubiquitination of caspase-9. Proc Natl Acad Sci USA. 2012; 109:10510-5. doi: 10.1073/pnas.1200094109.
40. Cooke JE, Kemp HA, Moens CB. EphA4 is required for cell adhesion and rhombomere-boundary formation in the zebrafish. Curr Biol. 2005; 15:536-42. doi: 10.1016/j. cub.2005.02.019.